Hamano Hiroki | Central Res. Laboratories Zeria Pharmaceutical Co. Ltd.

スポンサーリンク

概要

• 同名の論文著者
• Central Res. Laboratories Zeria Pharmaceutical Co. Ltd.の論文著者

関連著者

• Yoshinaga Koji

  Central Research Laboratories, Zeria Pharmaceutical Co., Ltd.

• Hamano Hiroki

  Central Research Laboratories, Zeria Pharmaceutical Co., Ltd.

• Orikawa Yuki

  Central Research Laboratories, Zeria Pharmaceutical Co., Ltd.

• Seto Koichi

  Central Research Laboratories, Zeria Pharmaceutical Co., Ltd.

• Takei Mineo

  Central Research Laboratories, Zeria Pharmaceutical Co., Ltd.

• Takei Mineo

  Central Research Laboratories Zeria Pharmaceutical Co. Ltd.

• Hamano Hiroki

  Central Res. Laboratories Zeria Pharmaceutical Co. Ltd.

• Yoshinaga Koji

  Central Res. Laboratories Zeria Pharmaceutical Co. Ltd.

• KURAISHI Yasushi

  Department of Applied Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, Univers

• Horii Takayuki

  Central Research Laboratories, Zeria Pharmaceutical Co., Ltd.

• Eta Runa

  Central Research Laboratories, Zeria Pharmaceutical Co., Ltd.

• Ozaki Tomoko

  Central Research Laboratories, Zeria Pharmaceutical Co., Ltd.

• Yoshii Kazuyoshi

  Central Research Laboratories, Zeria Pharmaceutical Co., Ltd.

• Kawabata Yoshihiro

  Central Research Laboratories, Zeria Pharmaceutical Co., Ltd.

• Hori Yuko

  Central Research Laboratories, Zeria Pharmaceutical Co., Ltd.

• Hori Yuko

  Central Res. Laboratories Zeria Pharmaceutical Co. Ltd.

• Yoshinaga Koji

  Central Research Laboratories Zeria Pharmaceutical Co. Ltd

• Kobayashi Nobuyoshi

  Central Research Laboratories, Zeria Pharmaceutical Co., Ltd.

• Kuraishi Yasushi

  Department Of Applied Pharmacology Faculty Of Pharmaceu Tical Sciences

• Kuraishi Yasushi

  Department Of Applide Biochemistry Research Institute For Wakan-yaku Toyama Toyama Medical And Pharm

もっと見る 閉じる

著作論文

• Pharmacological Evaluation of Analgesic Effects of the Cholecystokinin2 Receptor Antagonist Z-360 in Mouse Models of Formalin- and Cancer-Induced Pain
• Z-360, a Novel Cholecystokinin-2/Gastrin Receptor Antagonist, Inhibits Gemcitabine-Induced Expression of the Vascular Endothelial Growth Factor Gene in Human Pancreatic Cancer Cells

スポンサーリンク